Quest Diagnostics Inc  

(Public, NYSE:DGX)   Watch this stock  
Find more results for DGX
+0.68 (0.97%)
Real-time:   11:32AM EST
NYSE real-time data - Disclaimer
Currency in USD
Range 70.28 - 71.42
52 week 51.86 - 72.86
Open 70.29
Vol / Avg. 408,860.00/1.54M
Mkt cap 10.12B
P/E 18.70
Div/yield 0.38/2.15
EPS 3.79
Shares 144.31M
Beta 0.70
Inst. own 101%
Apr 22, 2015
Q1 2015 Quest Diagnostics Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Jan 29, 2015
Q4 2014 Quest Diagnostics Inc Earnings Release
Jan 29, 2015
Q4 2014 Quest Diagnostics Inc Earnings Call - Webcast
Jan 14, 2015
Quest Diagnostics Inc at JPMorgan Healthcare Conference
Jan 6, 2015
Quest Diagnostics Inc at Goldman Sachs CEOs Unscripted Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 10.36% 7.90%
Operating margin 13.65% 13.22%
EBITD margin - 18.04%
Return on average assets 7.78% 6.24%
Return on average equity 17.12% 13.31%
Employees 45,000 -
CDP Score - 83 C


3 Giralda Farms
United States - Map
+1-973-5202700 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Quest Diagnostics Incorporated (Quest Diagnostics) is a provider of diagnostic testing, information and services, providing insights that enable patients and physicians to make healthcare decisions. The Company�s operations are organized in two business groups, such as diagnostics information services and diagnostic solutions. Its diagnostics information services business is the provider of clinical testing services, gene-based, esoteric and anatomic pathology testing services and forensic drugs-of-abuse testing services. Its diagnostic solutions include Healthcare information technology, clinical trials testing, life insurer services and diagnostic products. The Company�s diagnostics products business manufactures and markets diagnostic test kits and specialized point-of-care testing. It offers a range of solutions, including urine, hair, blood and oral fluid tests.

Officers and directors

Stephen H. Rusckowski President, Chief Executive Officer, Director
Age: 57
Bio & Compensation  - Reuters
Mark J. Guinan Chief Financial Officer, Senior Vice President
Age: 52
Bio & Compensation  - Reuters
Lidia L. Fonseca Senior Vice President, Chief Information Officer
Age: 44
Bio & Compensation  - Reuters
Michael E. Prevoznik Senior Vice President, General Counsel
Age: 52
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Jon Roger Cohen M.D. Senior Vice President, Chief Medical Officer
Age: 59
Bio & Compensation  - Reuters
Everett V. Cunningham Senior Vice President - Commercial
Age: 47
Bio & Compensation  - Reuters
James E. Davis Senior Vice President - Operations
Age: 51
Bio & Compensation  - Reuters
Catherine T. Doherty Senior Vice President - Clinical Franchises
Age: 51
Bio & Compensation  - Reuters
Franklin R. Cockerill III, M.D. Vice President & Chief Laboratory Officer
Bio & Compensation  - Reuters
Daniel C. Stanzione Ph.D. Non-Executive Chairman of the Board
Age: 68
Bio & Compensation  - Reuters